Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Ashok Leyland Shares In Focus As Motilal Oswal Stays Bullish Despite Near-Term Headwinds — Check Target Price, Upside And More
Ashok Leyland delivered an in-line operational performance for Q4, with Motilal Oswal maintaining a bullish stance on the stock's long-term earnings outlook despite near-term demand uncertainties.
Premier Energies shares in focus as promoters sell stake worth Rs 2,289 crore. Check top buyers
Promoter family members of Premier Energies sold shares worth around Rs 2,289 crore through a block deal, while institutional investors, including Quant Mutual Fund and Nomura, picked up stakes. The development comes amid strong investor interest in renewable energy and domestic solar manufacturing, supported by robust earnings growth and aggressive capacity expansion plans.
Sun Pharma Shares In Focus As Motilal Oswal Retains Bullish Call After Q4 — Check Target Price, Upside
Sun Pharma delivered in-line revenue in Q4, whereas Ebitda/PAT came in lower than expected, dragged down by higher marketing spending and lower milestone income.
Zydus LifeSciences Shares in Focus: Motilal Oswal Maintains Neutral Rating on Limited Upside — Check Revised Target Price
The current valuation provides limited upside and hence, Motilal Oswal has maintained Neutral rating on Zydus Lifesciences.
After Nomura, Motilal Oswal also sees gold duty hike manageable for Titan
Motilal Oswal believes Titan is well-equipped to manage the situation through superior gold sourcing capabilities and a strong balance sheet.
Canara HSBC Life In Focus as Motilal Oswal Bets on Multi-Year Compounding Story — Check Target Price, Upside
The differentiated dual-bank partnership with mass scale from Canara Bank and premium affluence from HSBC creates a distribution backbone that only a few private life insurers possess.
SAIL Shares in Focus After Strong Q4; Motilal Oswal Stays Bullish With Higher Target Price — Check New Upside
SAIl remained in focus after Motilal Oswal reiterated its Buy rating on the stock and revised the target price upward.
JSW Steel and Radico Khaitan top Motilal Oswal's buy list after strong earnings
Siddhartha Khemka, Head of Research, Wealth Management at Motilal Oswal Financial Services, recommends Radico Khaitan (target ₹4,000) and JSW Steel (target ₹1,520) on strong earnings. He backs Adani Ports and Adani Power on volume growth and power demand. On OMCs, he sees limited downside post the ₹3 hike with HPCL as an interesting pick, while gold jewellery stocks may stay under near-term pressure.
Dixon Tech shares jump 6% despite weak Q4 results. Do Goldman Sachs, Motilal Oswal forecast further upside?
Dixon Technologies' shares saw a rally despite a 36% drop in March quarter net profit. Revenue from operations increased by 2% year-on-year. Brokerages offer mixed views, with Goldman Sachs maintaining a 'Sell' rating due to weaker mobile segment performance, while Motilal Oswal and JM Financial suggest 'Buy' and 'Add' respectively, citing potential growth drivers like PLI 2.0.
ONGC Shares in Focus as Royalty Rejig Improves Profit Outlook, Says Motilal Oswal — Check Target Price, Potential Upside And More
In the past few quarters, ONGC has struggled to raise production,sales, with no meaningful production, sales growth YoY for 9M FY26, adds Motilal Oswal.
Canara Bank shares rise over 2% after Q4 results. What are Morgan Stanley, Motilal Oswal saying?
Canara Bank shares rose after the lender reported a consolidated net profit of Rs 4,506 crore for Q4FY26, down 10% year-on-year and 13% sequentially. Despite the decline in profit, net interest income grew 4% YoY to Rs 9,808 crore.
Tata Consumer shares soar 7% after better-than-expected Q4 earnings. Here’s what Morgan Stanley & other top brokerages say
Tata Consumer Products shares rose sharply on Monday after strong Q4 earnings beat estimates. Consolidated net profit rose 21% YoY, supported by robust India-branded business performance. Brokerages including Morgan Stanley, Motilal Oswal and Elara Capital remain positive, projecting healthy growth, margin expansion and further upside for the FMCG major.